{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:51:16Z","timestamp":1740163876089,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P016502\/1"],"award-info":[{"award-number":["MR\/P016502\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mastocytosis Charity"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mastocytosis is a rare myeloproliferative disease, characterised by accumulation of neoplastic mast cells in one or several organs. It presents as cutaneous or systemic. Patients with advanced systemic mastocytosis have a median survival of 3.5\u00a0years. The aetiology of mastocytosis is poorly understood, patients present with a broad spectrum of varying clinical symptoms that lack specificity to point clearly to a definitive diagnosis. Discovery of novel blood borne biomarkers would provide a tractable method for rapid identification of mastocytosis and its sub-types. Moving towards this goal, we carried out a clinical biomarker study on blood from twenty individuals (systemic mastocytosis: n\u2009=\u200912, controls: n\u2009=\u20098), which were subjected to global proteome investigation using the novel technology SWATH-MS. This identified several putative biomarkers for systemic mastocytosis. Orthogonal validation of these putative biomarkers was achieved using ELISAs. Utilising this workflow, we identified and validated CXCL7, LBP, TGF\u03b21 and PDGF receptor-\u03b2 as novel biomarkers for systemic mastocytosis. We demonstrate that CXCL7 correlates with neutrophil count offering a new insight into the increased prevalence of anaphylaxis in mastocytosis patients. Additionally, demonstrating the utility of SWATH-MS for the discovery of novel biomarkers in the systemic mastocytosis diagnostic sphere.<\/jats:p>","DOI":"10.1038\/s41598-022-08345-3","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:05:51Z","timestamp":1648155951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["SWATH-MS identification of CXCL7, LBP, TGF\u03b21 and PDGFR\u03b2 as novel biomarkers in human systemic mastocytosis"],"prefix":"10.1038","volume":"12","author":[{"given":"R. L. J.","family":"Graham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. C.","family":"Dempsey-Hibbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"8345_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","volume":"13","author":"T Kristensen","year":"2011","unstructured":"Kristensen, T., Vestergaard, H. & M\u00f8ller, M. B. Improved detection of the KIT D816V Mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. J. Mol. Diagn. 13, 180\u2013188. https:\/\/doi.org\/10.1016\/j.jmoldx.2010.10.004 (2011).","journal-title":"J. Mol. Diagn."},{"key":"8345_CR2","doi-asserted-by":"crossref","unstructured":"Valent, P., Sperr, W. R. & Akin, C. How I Treat Patients with Advanced Systemic Mastocytosis. Vol. 116 (2010).","DOI":"10.1182\/blood-2010-08-292144"},{"key":"8345_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/bjh.12916","volume":"166","author":"SS Cohen","year":"2014","unstructured":"Cohen, S. S. et al. Epidemiology of systemic mastocytosis in Denmark. Br. J. Haematol. 166, 521\u2013528. https:\/\/doi.org\/10.1111\/bjh.12916 (2014).","journal-title":"Br. J. Haematol."},{"key":"8345_CR4","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.jaci.2012.10.015","volume":"131","author":"JJ van Doormaal","year":"2013","unstructured":"van Doormaal, J. J. et al. Prevalence of indolent systemic mastocytosis in a Dutch region. J. Allergy Clin. Immunol. 131, 1429-1431.e1421. https:\/\/doi.org\/10.1016\/j.jaci.2012.10.015 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"8345_CR5","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","volume":"374","author":"J Gotlib","year":"2016","unstructured":"Gotlib, J. et al. Efficacy and safety of midostaurin in advanced systemic mastocytosis. N. Engl. J. Med. 374, 2530\u20132541. https:\/\/doi.org\/10.1056\/NEJMoa1513098 (2016).","journal-title":"N. Engl. J. Med."},{"key":"8345_CR6","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","volume":"129","author":"P Valent","year":"2017","unstructured":"Valent, P., Akin, C. & Metcalfe, D. D. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood 129, 1420\u20131427. https:\/\/doi.org\/10.1182\/blood-2016-09-731893 (2017).","journal-title":"Blood"},{"key":"8345_CR7","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.3390\/ijms20122976","volume":"20","author":"P Valent","year":"2019","unstructured":"Valent, P. et al. Multidisciplinary challenges in mastocytosis and how to address with personalized medicine approaches. Int. J. Mol. Sci. 20, 2976. https:\/\/doi.org\/10.3390\/ijms20122976 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"8345_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/cyto.b.21336","volume":"90","author":"S Cherian","year":"2016","unstructured":"Cherian, S. et al. Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis. Cytometry B Clin. Cytom. 90, 387\u2013392. https:\/\/doi.org\/10.1002\/cyto.b.21336 (2016).","journal-title":"Cytometry B Clin. Cytom."},{"key":"8345_CR9","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1182\/blood-2013-01-453183","volume":"121","author":"A Pardanani","year":"2013","unstructured":"Pardanani, A. How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage). Blood 121, 3085\u20133094. https:\/\/doi.org\/10.1182\/blood-2013-01-453183 (2013).","journal-title":"Blood"},{"key":"8345_CR10","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood.2019000932","volume":"135","author":"A Reiter","year":"2020","unstructured":"Reiter, A., George, T. I. & Gotlib, J. New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis. Blood 135, 1365\u20131376. https:\/\/doi.org\/10.1182\/blood.2019000932 (2020).","journal-title":"Blood"},{"key":"8345_CR11","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1182\/blood-2019-130477","volume":"134","author":"C Oni","year":"2019","unstructured":"Oni, C. et al. UK single institution experience of mastocytosis: Guy\u2019s and St Thomas\u2019 NHS Foundation Trust. Blood 134, 2960\u20132960. https:\/\/doi.org\/10.1182\/blood-2019-130477 (2019).","journal-title":"Blood"},{"key":"8345_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/leu.2015.176","volume":"30","author":"A Mayado","year":"2016","unstructured":"Mayado, A. et al. Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression. Leukemia 30, 124\u2013130. https:\/\/doi.org\/10.1038\/leu.2015.176 (2016).","journal-title":"Leukemia"},{"key":"8345_CR13","first-page":"25","volume":"105","author":"H Horney","year":"2008","unstructured":"Horney, H., Sotlar, K. & Hartmann, K. Mastocytosis. Deutsches Arzteblatt Int. 105, 25 (2008).","journal-title":"Deutsches Arzteblatt Int."},{"key":"8345_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature19949","volume":"537","author":"R Aebersold","year":"2016","unstructured":"Aebersold, R. & Mann, M. Mass-spectrometric exploration of proteome structure and function. Nature 537, 347\u2013355. https:\/\/doi.org\/10.1038\/nature19949 (2016).","journal-title":"Nature"},{"key":"8345_CR15","unstructured":"Tate, S. H. C. MS\/MSALL with SWATH\u2122 acquisition\u2014comprehensive quantification with qualitative confirmation using the TripleTOF\u2122 5600 System. AB SCIEX: Technical note."},{"key":"8345_CR16","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/pmic.201200417","volume":"13","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS. Proteomics 13, 1247\u20131256. https:\/\/doi.org\/10.1002\/pmic.201200417 (2013).","journal-title":"Proteomics"},{"key":"8345_CR17","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.O111.016717","author":"LC Gillet","year":"2012","unstructured":"Gillet, L. C. et al. Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: A new concept for consistent and accurate proteome analysis. Mol. Cell. Proteom. https:\/\/doi.org\/10.1074\/mcp.O111.016717 (2012).","journal-title":"Mol. Cell. Proteom."},{"key":"8345_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.18632\/oncotarget.13648","volume":"8","author":"MR Russell","year":"2017","unstructured":"Russell, M. R. et al. Novel risk models for early detection and screening of ovarian cancer. Oncotarget 8, 785\u2013797. https:\/\/doi.org\/10.18632\/oncotarget.13648 (2017).","journal-title":"Oncotarget"},{"key":"8345_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41416-019-0544-0","volume":"121","author":"MR Russell","year":"2019","unstructured":"Russell, M. R. et al. Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel. Br. J. Cancer 121, 483\u2013489. https:\/\/doi.org\/10.1038\/s41416-019-0544-0 (2019).","journal-title":"Br. J. Cancer"},{"key":"8345_CR20","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1002\/ijc.30020","volume":"138","author":"MR Russell","year":"2016","unstructured":"Russell, M. R. et al. Protein Z: A putative novel biomarker for early detection of ovarian cancer. Int. J. Cancer 138, 2984\u20132992. https:\/\/doi.org\/10.1002\/ijc.30020 (2016).","journal-title":"Int. J. Cancer"},{"key":"8345_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cellsig.2018.11.004","volume":"54","author":"K Rajarathnam","year":"2019","unstructured":"Rajarathnam, K., Schnoor, M., Richardson, R. M. & Rajagopal, S. How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways. Cell Signal 54, 69\u201380. https:\/\/doi.org\/10.1016\/j.cellsig.2018.11.004 (2019).","journal-title":"Cell Signal"},{"key":"8345_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00185","author":"H Sandig","year":"2012","unstructured":"Sandig, H. & Bulfone-Paus, S. TLR signaling in mast cells: Common and unique features. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2012.00185 (2012).","journal-title":"Front. Immunol."},{"key":"8345_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00868","author":"HL Caslin","year":"2018","unstructured":"Caslin, H. L. et al. Controlling mast cell activation and homeostasis: Work influenced by bill Paul that continues today. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.00868 (2018).","journal-title":"Front. Immunol."},{"key":"8345_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00620","author":"M Krystel-Whittemore","year":"2016","unstructured":"Krystel-Whittemore, M., Dileepan, K. N. & Wood, J. G. Mast cell: A multi-functional master cell. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2015.00620 (2016).","journal-title":"Front. Immunol."},{"key":"8345_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","volume":"124","author":"L Escribano","year":"2009","unstructured":"Escribano, L. et al. Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J. Allergy Clin. Immunol. 124, 514\u2013521. https:\/\/doi.org\/10.1016\/j.jaci.2009.05.003 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"8345_CR26","doi-asserted-by":"publisher","first-page":"1500522","DOI":"10.1002\/pmic.201500522","volume":"17","author":"Y Kang","year":"2017","unstructured":"Kang, Y., Burton, L., Lau, A. & Tate, S. SWATH-ID: An instrument method which combines identification and quantification in a single analysis. Proteomics 17, 1500522. https:\/\/doi.org\/10.1002\/pmic.201500522 (2017).","journal-title":"Proteomics"},{"key":"8345_CR27","doi-asserted-by":"publisher","first-page":"e0193799","DOI":"10.1371\/journal.pone.0193799","volume":"13","author":"E Miyauchi","year":"2018","unstructured":"Miyauchi, E. et al. Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics. PLoS\u00a0One 13, e0193799. https:\/\/doi.org\/10.1371\/journal.pone.0193799 (2018).","journal-title":"PLoS\u00a0One"},{"key":"8345_CR28","doi-asserted-by":"publisher","first-page":"1800008","DOI":"10.1002\/prca.201800008","volume":"12","author":"M Zhao","year":"2018","unstructured":"Zhao, M. et al. A comparative proteomics analysis of five body fluids: Plasma, urine, cerebrospinal fluid, amniotic fluid, and saliva. Proteom. Clin. Appl. 12, 1800008. https:\/\/doi.org\/10.1002\/prca.201800008 (2018).","journal-title":"Proteom. Clin. Appl."},{"key":"8345_CR29","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1182\/blood-2005-06-2424","volume":"107","author":"F Schiemann","year":"2006","unstructured":"Schiemann, F. et al. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G. Blood 107, 2234\u20132242. https:\/\/doi.org\/10.1182\/blood-2005-06-2424 (2006).","journal-title":"Blood"},{"key":"8345_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01248","author":"AJ Brown","year":"2017","unstructured":"Brown, A. J., Sepuru, K. M., Sawant, K. V. & Rajarathnam, K. Platelet-derived chemokine CXCL7 dimer preferentially exists in the glycosaminoglycan-bound form: Implications for neutrophil-platelet crosstalk. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.01248 (2017).","journal-title":"Front. Immunol."},{"key":"8345_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11882-009-0010-9","volume":"9","author":"UR M\u00fcller","year":"2009","unstructured":"M\u00fcller, U. R. & Haeberli, G. The problem of anaphylaxis and mastocytosis. Curr. Allergy Asthma Rep. 9, 64\u201370. https:\/\/doi.org\/10.1007\/s11882-009-0010-9 (2009).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"8345_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/cea.12868","volume":"47","author":"A Francis","year":"2017","unstructured":"Francis, A. et al. Neutrophil activation during acute human anaphylaxis: Analysis of MPO and sCD62L. Clin. Exp. Allergy 47, 361\u2013370. https:\/\/doi.org\/10.1111\/cea.12868 (2017).","journal-title":"Clin. Exp. Allergy"},{"key":"8345_CR33","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1172\/JCI45232","volume":"121","author":"F J\u00f6nsson","year":"2011","unstructured":"J\u00f6nsson, F. et al. Mouse and human neutrophils induce anaphylaxis. J. Clin. Investig. 121, 1484\u20131496. https:\/\/doi.org\/10.1172\/JCI45232 (2011).","journal-title":"J. Clin. Investig."},{"key":"8345_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.7150\/ijbs.8.228","volume":"8","author":"G Han","year":"2012","unstructured":"Han, G., Li, F., Singh, T. P., Wolf, P. & Wang, X.-J. The pro-inflammatory role of TGF\u03b21: A paradox?. Int. J. Biol. Sci. 8, 228\u2013235. https:\/\/doi.org\/10.7150\/ijbs.8.228 (2012).","journal-title":"Int. J. Biol. Sci."},{"key":"8345_CR35","doi-asserted-by":"publisher","first-page":"866","DOI":"10.4049\/jimmunol.1601983","volume":"199","author":"VS Ndaw","year":"2017","unstructured":"Ndaw, V. S. et al. TGF-\u03b21 suppresses IL-33-induced mast cell function. J. Immunol. 199, 866\u2013873. https:\/\/doi.org\/10.4049\/jimmunol.1601983 (2017).","journal-title":"J. Immunol."},{"key":"8345_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000048182","volume":"127","author":"CY Li","year":"2002","unstructured":"Li, C. Y. & Baek, J. Y. Mastocytosis and fibrosis: Role of cytokines. Int. Arch. Allergy Immunol. 127, 123\u2013126. https:\/\/doi.org\/10.1159\/000048182 (2002).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"8345_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1172\/JCI19540","volume":"113","author":"M Shehata","year":"2004","unstructured":"Shehata, M. et al. TGF-\u03b21 induces bone marrow reticulin fibrosis in hairy cell leukemia. J. Clin. Investig. 113, 676\u2013685. https:\/\/doi.org\/10.1172\/JCI19540 (2004).","journal-title":"J. Clin. Investig."},{"key":"8345_CR38","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544 (2016).","journal-title":"Blood"},{"key":"8345_CR39","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3324\/haematol.2017.179895","volume":"103","author":"M Schneeweiss","year":"2018","unstructured":"Schneeweiss, M. et al. The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis. Haematologica 103, 799\u2013809. https:\/\/doi.org\/10.3324\/haematol.2017.179895 (2018).","journal-title":"Haematologica"},{"key":"8345_CR40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.semarthrit.2017.05.004","volume":"47","author":"K Ntelis","year":"2017","unstructured":"Ntelis, K., Solomou, E. E., Sakkas, L., Liossis, S.-N. & Daoussis, D. The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis. Semin. Arthritis Rheum. 47, 409\u2013417. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.05.004 (2017).","journal-title":"Semin. Arthritis Rheum."},{"key":"8345_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00428-013-1434-0","volume":"463","author":"J Bedekovics","year":"2013","unstructured":"Bedekovics, J., Kiss, A., Beke, L., K\u00e1rolyi, K. & M\u00e9hes, G. Platelet derived growth factor receptor-beta (PDGFR\u03b2) expression is limited to activated stromal cells in the bone marrow and shows a strong correlation with the grade of myelofibrosis. Virchows Arch. 463, 57\u201365. https:\/\/doi.org\/10.1007\/s00428-013-1434-0 (2013).","journal-title":"Virchows Arch."},{"key":"8345_CR42","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896\u20131906. https:\/\/doi.org\/10.1038\/nprot.2007.261 (2007).","journal-title":"Nat. Protoc."},{"key":"8345_CR43","unstructured":"Sciex, A. Improved Data Quality Using Variable Q1 Window Widths in SWATH\u00ae Acquisition. (2017). https:\/\/sciex.com\/content\/dam\/SCIEX\/pdf\/tech-notes\/all\/Variable_Window_SWATH_Acquisition_TripleTOF_RUO-MKT-02-2879-B.pdf."},{"key":"8345_CR44","doi-asserted-by":"publisher","first-page":"140031","DOI":"10.1038\/sdata.2014.31","volume":"1","author":"G Rosenberger","year":"2014","unstructured":"Rosenberger, G. et al. A repository of assays to quantify 10,000 human proteins by SWATH-MS. Sci. Data 1, 140031. https:\/\/doi.org\/10.1038\/sdata.2014.31 (2014).","journal-title":"Sci. Data"},{"key":"8345_CR45","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12859-018-2533-3","volume":"19","author":"M Pomaznoy","year":"2018","unstructured":"Pomaznoy, M., Ha, B. & Peters, B. GOnet: A tool for interactive Gene Ontology analysis. BMC Bioinform. 19, 470. https:\/\/doi.org\/10.1186\/s12859-018-2533-3 (2018).","journal-title":"BMC Bioinform."},{"key":"8345_CR46","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","volume":"44","author":"JA Vizca\u00edno","year":"2015","unstructured":"Vizca\u00edno, J. A. et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 44, D447\u2013D456. https:\/\/doi.org\/10.1093\/nar\/gkv1145 (2015).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08345-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08345-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08345-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:50:51Z","timestamp":1669337451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08345-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8345"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08345-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"28 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5087"}}